Biomaterial Database

Indomethacin as a tocolytic agent: the controversy continues. 1994

J D Merrill, and R I Clyman, and M E Norton

UI	MeSH Term	Description	Entries
D007213	Indomethacin	A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.	Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D007231	Infant, Newborn	An infant during the first 28 days after birth.	Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007235	Infant, Premature, Diseases	Diseases that occur in PREMATURE INFANTS.
D007752	Obstetric Labor, Premature	Onset of OBSTETRIC LABOR before term (TERM BIRTH) but usually after the FETUS has become viable. In humans, it occurs sometime during the 29th through 38th week of PREGNANCY. TOCOLYSIS inhibits premature labor and can prevent the BIRTH of premature infants (INFANT, PREMATURE).	Preterm Labor,Labor, Premature,Premature Labor,Premature Obstetric Labor,Labor, Premature Obstetric,Labor, Preterm
D011247	Pregnancy	The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.	Gestation,Pregnancies
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015145	Tocolysis	Any drug treatment modality designed to inhibit UTERINE CONTRACTION. It is used in pregnant women to arrest PREMATURE LABOR.	Tocolytic Therapy,Therapy, Tocolytic,Tocolytic Treatment,Therapies, Tocolytic,Tocolyses,Tocolytic Therapies,Tocolytic Treatments,Treatment, Tocolytic,Treatments, Tocolytic
D015149	Tocolytic Agents	Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete.	Tocolytic,Tocolytic Agent,Tocolytic Effect,Tocolytic Effects,Tocolytics,Agent, Tocolytic,Agents, Tocolytic,Effect, Tocolytic,Effects, Tocolytic

Related Publications

J D Merrill, and R I Clyman, and M E Norton

Fetal and neonatal effects of indomethacin used as a tocolytic agent.

January 1985, American journal of obstetrics and gynecology,

J D Merrill, and R I Clyman, and M E Norton

Fetal and neonatal effects of indomethacin used as a tocolytic agent.

November 1985, American journal of obstetrics and gynecology,

J D Merrill, and R I Clyman, and M E Norton

Fetal and neonatal effects of indomethacin used as a tocolytic agent.

December 1985, American journal of obstetrics and gynecology,

J D Merrill, and R I Clyman, and M E Norton

[Indomethacin and a tocolytic agent: fetal and neonatal outcome].

December 1990, Harefuah,

J D Merrill, and R I Clyman, and M E Norton

Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function.

October 1990, Obstetrics and gynecology,

J D Merrill, and R I Clyman, and M E Norton

Acute renal failure in the neonate induced by the administration of indomethacin as a tocolytic agent.

June 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,

J D Merrill, and R I Clyman, and M E Norton

Indomethacin as a tocolytic harmful to preterm infant.

December 2015, American journal of obstetrics and gynecology,

J D Merrill, and R I Clyman, and M E Norton

Magnesium sulfate as a tocolytic agent.

August 2001, Seminars in perinatology,

J D Merrill, and R I Clyman, and M E Norton

Magnesium sulfate as a tocolytic agent.

October 1983, American journal of obstetrics and gynecology,

J D Merrill, and R I Clyman, and M E Norton

The controversy continues!!

February 2008, International journal of oral and maxillofacial surgery,